Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Peripheral Biomarkers RFP

    Forecasted

    Peripheral Biomarkers RFP supports researchers and clinicians developing and validating peripheral biomarkers to advance drug development for Alzheimer's disease and related dementias.

    Browse similar grants
    Foundation Grants for Biomedical ResearchNeuroscience Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Alzheimer's Drug Discovery Foundation

    Due Dates: Due Dates (Anticipated): Not yet announced

    Funding Amounts: Exploratory: generally up to approximately $250,000; proof-of-principle: generally up to $500,000; validation: based on stage and scope

    Summary: Supports peripheral biomarker development and validation to advance drug development for Alzheimer's disease and related dementias.

    Key Information: For-profit companies receive mission-related investments requiring a return on investment.


    Description

    The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator supports peripheral biomarkers that advance drug development for Alzheimer's disease and related dementias. The program encourages blood, saliva, urine, and ocular biomarkers with a rational biological connection to disease processes. It covers diagnostic, monitoring, predictive, prognostic, pharmacodynamic/response, safety, and susceptibility/risk biomarkers.

    Research priorities include vascular injury and blood-brain barrier integrity, neuroinflammation, neuroprotection and neurodegeneration, frontotemporal degeneration, protein misfolding, synaptic integrity or activity, and mitochondrial and metabolic function. Other approaches supported by compelling biological evidence are encouraged. Supported work ranges from pilot studies through larger clinical validation studies, with emphasis on reliable assays, reproducibility, well-characterized samples, and a path toward commercialization. Development of CSF and neuroimaging biomarkers is excluded, although these tools may validate peripheral biomarkers.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.